pyrroles has been researched along with pentylenetetrazole in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.14) | 18.7374 |
| 1990's | 4 (28.57) | 18.2507 |
| 2000's | 2 (14.29) | 29.6817 |
| 2010's | 7 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baeyens, JM; Barrios, M; Del Pozo, E | 1 |
| Freeman, JJ; Kosh, JW; Powers, DL; Sowell, JW | 1 |
| Malinka, W; Tatarczyńska, E | 1 |
| Almond, HR; Carmosin, RJ; Carson, JR; Pitis, PM; Stables, JP; Swinyard, EA; Vaught, JL; White, HS; Wolf, HH | 1 |
| Engel, J; Günther, R; Höfgen, N; Hofmann, HJ; Lankau, HJ; Liebscher, J; Menzer, M; Müller, B; Rolfs, A; Rostock, A; Unverferth, K | 1 |
| Ashkenazi, S; Chrousos, GP; Ovadia, H; Weizman, A; Yuhas, Y | 1 |
| Arnold, T; Dost, R; Egerland, U; Grunwald, C; Höfgen, N; Hofmann, HJ; Lankau, HJ; Rundfeldt, C; Unverferth, K | 1 |
| Akgün-Dar, K; Aksu, U; Uzüm, G | 1 |
| de Mello, CF; de Oliveira, CV; Ferreira, J; Funck, VR; Furian, AF; Guerra, GP; Mallmann, CA; Oliveira, MS; Pereira, LM; Rambo, LM; Ribeiro, LR; Royes, LF | 1 |
| Dehpour, AR; Fakhrzad, A; Hassanipour, M; Hassanpour, S; Moezi, L; Shafaroodi, H | 1 |
| Emamzadeh-Fard, S; Moazzami, K; Shabani, M | 1 |
| Dehpour, AR; Fakhrzad, A; Hassanipour, M; Moezi, L; Rezayat, M; Shafaroodi, H | 1 |
| Chońska, J; Dawidowski, M; Mika, W; Turło, J | 1 |
| Bhardwaj, V; Bharti, R; Das, P; Kumari, S; Mazumder, AG; Purohit, R; Singh, D; Tanwar, G | 1 |
14 other study(ies) available for pyrroles and pentylenetetrazole
| Article | Year |
|---|---|
Effects of potassium channel openers on pentylenetetrazole-induced seizures in mice.
Topics: 4-Aminopyridine; Animals; Benzopyrans; Cromakalim; Drug Antagonism; Female; Guanidines; Mice; Pentylenetetrazole; Pinacidil; Potassium Channels; Pyrroles; Seizures | 1990 |
Anticonvulsant properties of selected pyrrolo[2,3-d]pyrimidine-2,4-diones and intermediates.
Topics: Animals; Anticonvulsants; Electroshock; Male; Mice; Pentylenetetrazole; Phenytoin; Pyrimidinones; Pyrroles; Seizures; Solubility; Structure-Activity Relationship; Trimethadione | 1980 |
Synthesis and pharmacological properties of N-(4-substituted-1-piperazinylalkyl)-1-butyl-2,5-dimethylpyrrole-3,4- dicarboxyimide derivatives.
Topics: Animals; Anticonvulsants; Apomorphine; Central Nervous System Agents; Chemical Phenomena; Chemistry, Physical; Fever; Helplessness, Learned; Lethal Dose 50; Magnetic Resonance Spectroscopy; Male; Mice; Motor Activity; Pain Measurement; Pentylenetetrazole; Piperazines; Pyrroles; Rats; Rats, Wistar; Reserpine; Serotonin Receptor Agonists | 1993 |
Aroyl(aminoacyl)pyrroles, a new class of anticonvulsant agents.
Topics: Anesthesia; Animals; Anticonvulsants; Bicuculline; Calcium; Cerebellum; Electroshock; Mice; Models, Molecular; Molecular Structure; Pentylenetetrazole; Piperidines; Potassium; Pyrroles; Rats; Seizures; Structure-Activity Relationship; Veratridine | 1997 |
Synthesis, anticonvulsant activity, and structure-activity relationships of sodium channel blocking 3-aminopyrroles.
Topics: Animals; Anticonvulsants; Dose-Response Relationship, Drug; Electroshock; Indicators and Reagents; Male; Mice; Models, Molecular; Molecular Structure; Motor Activity; Neurotoxins; Pentylenetetrazole; Pyrroles; Rats; Rats, Sprague-Dawley; Seizures; Sodium Channel Blockers; Structure-Activity Relationship | 1998 |
Involvement of the neuropeptide corticotropin-releasing hormone in an animal model of Shigella-related seizures.
Topics: Animals; Corticotropin-Releasing Hormone; Disease Models, Animal; Male; Mice; Mice, Inbred ICR; Pentylenetetrazole; Pyrimidines; Pyrroles; Seizures; Shigella; Time Factors | 2004 |
Synthesis, pharmacology, and structure-activity relationships of novel imidazolones and pyrrolones as modulators of GABAA receptors.
Topics: Administration, Oral; Animals; Anti-Anxiety Agents; Anticonvulsants; Binding Sites; Brain; GABA Antagonists; GABA-A Receptor Agonists; Imidazoles; Male; Mice; Models, Molecular; Morpholines; Pentylenetetrazole; Piperidines; Pyrroles; Quantitative Structure-Activity Relationship; Radioligand Assay; Rats; Rats, Wistar; Rotarod Performance Test; Seizures | 2006 |
The effects of atorvastatin on memory deficit and seizure susceptibility in pentylentetrazole-kindled rats.
Topics: Analysis of Variance; Animals; Anticholesteremic Agents; Atorvastatin; Avoidance Learning; Disease Susceptibility; Electroencephalography; Heptanoic Acids; Kindling, Neurologic; Male; Memory Disorders; Pentylenetetrazole; Pyrroles; Rats; Rats, Wistar; Reaction Time; Seizures | 2010 |
Differential effects of atorvastatin treatment and withdrawal on pentylenetetrazol-induced seizures.
Topics: Animals; Anticonvulsants; Atorvastatin; Blood-Brain Barrier; Cerebral Cortex; Cholesterol; Convulsants; Electroencephalography; Heptanoic Acids; Male; Pentylenetetrazole; Pyrroles; Rats; Rats, Wistar; Seizures; Simvastatin | 2011 |
Chronic administration of atorvastatin induced anti-convulsant effects in mice: the role of nitric oxide.
Topics: Analysis of Variance; Animals; Anticonvulsants; Atorvastatin; Convulsants; Disease Models, Animal; Drug Administration Routes; Drug Administration Schedule; Drug Interactions; Enzyme Inhibitors; Guanidines; Heptanoic Acids; Male; Mice; NG-Nitroarginine Methyl Ester; Nitric Oxide; Pentylenetetrazole; Pyrroles; Seizures; Time Factors | 2012 |
Anticonvulsive effect of atorvastatin on pentylenetetrazole-induced seizures in mice: the role of nitric oxide pathway.
Topics: Animals; Anticonvulsants; Arginine; Atorvastatin; Heptanoic Acids; Male; Mice; NG-Nitroarginine Methyl Ester; Nitric Oxide; Pentylenetetrazole; Pyrroles; Seizures; Signal Transduction | 2013 |
The involvement of nitric oxide in the anti-seizure effect of acute atorvastatin treatment in mice.
Topics: Animals; Anticonvulsants; Atorvastatin; Brain; Convulsants; Disease Models, Animal; Dose-Response Relationship, Drug; Electroshock; Enzyme Inhibitors; Epilepsy, Tonic-Clonic; Guanidines; Heptanoic Acids; Male; Mice; NG-Nitroarginine Methyl Ester; Nitric Oxide; Pentylenetetrazole; Pyrroles | 2012 |
Novel fluorinated pyrrolo[1,2-a]pyrazine-2,6-dione derivatives: synthesis and anticonvulsant evaluation in animal models of epilepsy.
Topics: Animals; Anticonvulsants; Disease Models, Animal; Dose-Response Relationship, Drug; Electroshock; Epilepsy; Halogenation; Hydrocarbons, Fluorinated; Male; Mice; Molecular Structure; Pentylenetetrazole; Pilocarpine; Pyrazines; Pyrroles; Rats; Rats, Sprague-Dawley; Seizures; Structure-Activity Relationship | 2014 |
Target identification, screening and in vivo evaluation of pyrrolone-fused benzosuberene compounds against human epilepsy using Zebrafish model of pentylenetetrazol-induced seizures.
Topics: Animals; Anticonvulsants; Class I Phosphatidylinositol 3-Kinases; Coumarins; Disease Models, Animal; Drug Evaluation, Preclinical; Epilepsy; Gene Expression Profiling; Gene Expression Regulation; Humans; Molecular Docking Simulation; Pentylenetetrazole; Proto-Oncogene Proteins c-akt; Pyrroles; Signal Transduction; TOR Serine-Threonine Kinases; Zebrafish; Zebrafish Proteins | 2019 |